Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: OssDsign AB (publ)

Market Cap 462M 48.14M 42.07M 38.91M 36.32M 68.18M 4.55B 68.68M 180M 2.24B 181M 177M 7.77B P/E 2026 *
-8.96x
P/E 2027 * -12.8x
Enterprise Value 345M 35.96M 31.42M 29.07M 27.13M 50.93M 3.4B 51.31M 134M 1.67B 135M 132M 5.8B EV / Sales 2026 *
2.06x
EV / Sales 2027 * 1.68x
Free-Float
67.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 63 01/01/2020
Chief Tech/Sci/R&D Officer 47 01/01/2022
Director TitleAgeSince
Chairman 66 20/04/2016
Director/Board Member 60 01/01/2022
Director/Board Member 61 25/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 47.81M
-1.01%-1.06%-18.87%+2.28% 118B
-1.02%-1.55%+3.15%-8.99% 12.63B
+0.39%+0.81%+30.99%+95.43% 7.67B
+0.89%-1.54%-46.25%-70.77% 4.07B
-1.23%-1.72%+18.00%+36.84% 2.55B
-2.67%-3.28%-16.52%-15.40% 1.77B
-0.78%-3.00%+3.45%-21.06% 1.59B
+4.14%+15.49%+201.37%+165.46% 1.49B
Average -4.16%+0.15%+21.92%+22.97% 18.72B
Weighted average by Cap. -0.87%-0.94%-12.12%+5.87%

Financials

2026 *2027 *
Net sales 168M 17.44M 15.24M 14.1M 13.16M 24.7M 1.65B 24.88M 65.19M 810M 65.49M 64.07M 2.82B 238M 24.81M 21.68M 20.06M 18.72M 35.14M 2.34B 35.4M 92.73M 1.15B 93.16M 91.15M 4.01B
Net income -51.27M -5.34M -4.66M -4.31M -4.03M -7.56M -504M -7.61M -19.95M -248M -20.04M -19.61M -862M -35.73M -3.72M -3.25M -3.01M -2.81M -5.27M -352M -5.31M -13.9M -173M -13.97M -13.67M -601M
Net Debt -117M -12.18M -10.64M -9.85M -9.19M -17.25M -1.15B -17.38M -45.52M -566M -45.74M -44.74M -1.97B -63M -6.56M -5.73M -5.3M -4.95M -9.29M -620M -9.36M -24.51M -305M -24.63M -24.09M -1.06B
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
35
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!